How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Synthetic Organic Chemistry industry affect EB-2 NIW petition outcomes?

The Synthetic Organic Chemistry sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW)

Associate Research Scientist

Synthetic Organic Chemistry · India · 2023-10-20

Processing Time

25 days

Decision Date

2023-10-20

Location

Indiana

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing small-molecule ligands and chemical constituents for use in drug discovery and pharmaceutical development. This work focuses on the creation of anti-diabetic and anti-cancer compounds, as well as the design of FAP-targeted ligands with therapeutic applications. The research aims to advance pharmaceutical innovation and improve human health outcomes through more efficient drug synthesis methodologies.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The endeavor was found to have national importance due to its direct impact on the pharmaceutical industry and the development of life-saving anti-cancer and anti-diabetic medications.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 13 publications, 6 patent applications, and 207 citations established a track record of success and leadership in synthetic organic chemistry.

3 On Balance, Beneficial to Waive Job Offer Met

USCIS determined that the urgency of pharmaceutical innovation and the petitioner's unique expertise made a waiver of the labor certification requirement beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's significant contributions to synthetic chemistry, including 13 peer-reviewed scientific articles and 6 patent applications. The work has garnered 207 citations from researchers in at least 27 countries and includes over 40 peer reviews, demonstrating a high level of influence in the field. The evidence satisfied all three Dhanasar prongs by showing the national importance of pharmaceutical innovation and the petitioner's strong positioning through academic and patent output.

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Patents

Reference Letters Dependent

Judging Experience

Original Contributions

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved

Wisconsin 94 days 2025-01-29

The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

View Case

Chemist

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved

Pennsylvania 364 days 2025-11-26

The petitioner proposes to develop practical and efficient synthetic routes to produce active pharmaceutical ingredients (APIs) for drugs currently in clinical trials. This work focuses on improving scalable production methods to reduce costs and shorten development timelines for new therapies targeting cancer and neurodegenerative disorders.

View Case

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved

California 467 days 2025-03-05

The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.

View Case

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved

278 days 2025-01-11

The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-10-20.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 25 days

Criteria Met 3 / 3

Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813

Success Rate 53.7%

Sustained 2,046

Dismissed 1,671

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Associate Research Scientist

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Evidence

Similar Cases

Scientist

Chemist

Scientist

Postdoctoral Researcher

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights